Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome
- PMID: 37440963
- PMCID: PMC10334485
- DOI: 10.1210/jendso/bvad087
Recognition of Nonneoplastic Hypercortisolism in the Evaluation of Patients With Cushing Syndrome
Abstract
The evaluation of suspected hypercortisolism is one of the most challenging problems in medicine. The signs and symptoms described by Dr Harvey Cushing are common and often create diagnostic confusion to even experienced endocrinologists. Cushing syndrome is classically defined as neoplastic hypercortisolism resulting from an ACTH-secreting tumor or from autonomous secretion of excess cortisol associated with benign or malignant adrenal neoplasia. The increasing recognition of the negative cardiometabolic effects of mild cortisol excess without overt physical signs of Cushing syndrome has led to more screening for endogenous hypercortisolism in patients with adrenal nodular disease, osteoporosis, and the metabolic syndrome. However, sustained or intermittent activation of the dynamic hypothalamic-pituitary-adrenal axis caused by chemical (alcohol), inflammatory (chronic kidney disease), psychologic (major depression), and physical (starvation/chronic intense exercise) stimuli can result in clinical and/or biochemical features indistinguishable from neoplastic hypercortisolism. Nonneoplastic hypercortisolism (formerly known as pseudo-Cushing syndrome) has been recognized for more than 50 years and often causes diagnostic uncertainty. This expert consultation describes two patients with features of Cushing syndrome who were referred for inferior petrosal sinus sampling for the differential diagnosis of ACTH-dependent hypercortisolism. Both patients were discovered to have nonneoplastic hypercortisolism: one from a covert alcohol use disorder and the other to chronic kidney disease. This consultation emphasizes the value of a good history and physical examination, appropriate laboratory testing, and the desmopressin acetate stimulation test to aid in distinguishing neoplastic from nonneoplastic hypercortisolism.
Keywords: ACTH; Cushing disease; corticotrophs; cortisol; desmopressin; hypothalamic-pituitary-adrenal axis.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.
Figures
Similar articles
-
The difficulties of pseudo-Cushing's syndrome (or "non-neoplastic hypercortisolism").Ann Endocrinol (Paris). 2018 Jun;79(3):138-145. doi: 10.1016/j.ando.2018.04.017. Epub 2018 Apr 30. Ann Endocrinol (Paris). 2018. PMID: 29716734 Review.
-
Alcohol-induced Cushing syndrome: report of eight cases and review of the literature.Front Endocrinol (Lausanne). 2023 Jun 20;14:1199091. doi: 10.3389/fendo.2023.1199091. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37409223 Free PMC article. Review.
-
DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).Eur J Endocrinol. 2017 May;176(5):R205-R216. doi: 10.1530/EJE-16-0946. Epub 2017 Feb 8. Eur J Endocrinol. 2017. PMID: 28179447 Review.
-
ACTH-dependent Cushing Syndrome with No Peripheral Response But a Marked Petrosal Sinus ACTH Response to Desmopressin.JCEM Case Rep. 2024 May 27;2(6):luae092. doi: 10.1210/jcemcr/luae092. eCollection 2024 Jun. JCEM Case Rep. 2024. PMID: 38803508 Free PMC article.
-
Pseudo-Cushing Syndrome With an Atypically High Cortisol Burden and Clinical Improvement With Adrenal Enzyme Inhibitor.JCEM Case Rep. 2023 Jul 1;1(4):luad075. doi: 10.1210/jcemcr/luad075. eCollection 2023 Jul. JCEM Case Rep. 2023. PMID: 37909002 Free PMC article.
Cited by
-
Overnight 1-mg DST Serum Cortisol in Various Stages of Chronic Kidney Disease-Normative Data and Underlying Mechanisms.J Endocr Soc. 2024 Jan 12;8(3):bvae002. doi: 10.1210/jendso/bvae002. eCollection 2024 Jan 16. J Endocr Soc. 2024. PMID: 38249430 Free PMC article.
-
The Overnight Low-Dose Dexamethasone Suppression Test Can Be Used to Evaluate Patients With Chronic Kidney Disease.J Endocr Soc. 2024 Jan 29;8(3):bvae007. doi: 10.1210/jendso/bvae007. eCollection 2024 Jan 16. J Endocr Soc. 2024. PMID: 38292594 Free PMC article. No abstract available.
-
Accuracy of the 10 μg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 Jan 30;15:1332120. doi: 10.3389/fendo.2024.1332120. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38352712 Free PMC article.
-
Differential diagnosis between Cushing's syndrome and non-neoplastic hypercortisolism: are we getting there?Pituitary. 2024 Oct;27(5):451-454. doi: 10.1007/s11102-024-01458-0. Epub 2024 Sep 19. Pituitary. 2024. PMID: 39298060 No abstract available.
-
Cushing syndrome in paediatric population: who and how to screen.J Endocrinol Invest. 2024 Sep 30. doi: 10.1007/s40618-024-02452-w. Online ahead of print. J Endocrinol Invest. 2024. PMID: 39347909 Review.
References
-
- Lindholm J. Cushing's syndrome: historical aspects. Pituitary. 2000;3(2):97‐104. - PubMed
-
- Aron DC. Cushing's syndrome from bedside to bench and back: a historical perspective. Endocrinol Metab Clin North Am. 2005;34(2):257‐269, vii. - PubMed
-
- Kelsall A, Newell-Price J. Cushing's disease-from Minnie G to key issues in the early 21st century. Lancet Diabetes Endocrinol. 2019;7(12):959‐964. - PubMed
-
- Di Dalmazi G, Pasquali R, Beuschlein F, Reincke M. Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur J Endocrinol. 2015;173(4):M61‐M71. - PubMed
LinkOut - more resources
Full Text Sources